Home › Companies › Edgewise Therapeutics, Inc. › 2024-2025

Edgewise Therapeutics, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings. Page generated November 1, 2026.

  • 7Reported items
  • 199Asset managers
  • 1,392Fund votes
  • June 13, 2025Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from Edgewise Therapeutics, Inc. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore Edgewise Therapeutics, Inc. in the interactive database Compare manager voting policies

How asset managers voted at the Edgewise Therapeutics, Inc. 2024-2025 meeting

Each item below shows how the 199 asset managers that disclosed a Edgewise Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Edgewise Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting…: Alan Russell, Ph.D.

No official resultsDIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

84% of fund votes cast · no official result

FORWITHHOLD
Details: description as filed, votes by 64 asset managers

Description as filed by funds: Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of Stockholders: Alan Russell, Ph.D.

The 64 asset managers below reported 14,071,411 for, 2,732,491 withheld, 329,406 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 14,071,411ABSTAIN: 329,406WITHHOLD: 2,732,491
Largest asset managers voting on “Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of Stockholde” at Edgewise Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard4,610,1600 00For
BlackRock2,864,4980 00For
Fidelity1,589,3580 0514,930Mixed
JANUS INVESTMENT FUND1,438,9080 00For
Artisan856,3800 00For
American Century00 0613,417Withhold
Charles Schwab579,7040 00For
MUTUAL FUND SERIES TRUST568,3100 08,025For
Aberdeen443,3190 00For
Victory Capital00 0383,815Withhold
DRIEHAUS MUTUAL FUNDS00 0349,368Withhold
Federated Hermes292,4540 00For
State Street00 0246,557Withhold
Equitable193,8620 00For
TIAA193,4540 00For
Bridge Builder Trust14,4160 147,9390Mixed
QUANTITATIVE MASTER SERIES LLC127,3880 00For
AIG/SunAmerica00 0117,285Withhold
Lincoln Financial00 099,997Withhold
Jackson National00 88,1410Abstain
Prudential/PGIM00 074,554Withhold
ALPS ETF Trust00 068,275Withhold
TRUST FOR PROFESSIONAL MANAGERS00 64,0230Abstain
Neuberger Berman53,2830 00For
RBB FUND, INC.00 049,380Withhold

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

2. Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of…: Arlene Morris

No official resultsDIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

57% of fund votes cast · no official result

FORABSTAINWITHHOLD
Details: description as filed, votes by 64 asset managers

Description as filed by funds: Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of Stockholders: Arlene Morris

The 64 asset managers below reported 7,835,400 for, 5,917,847 withheld, 3,380,061 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 7,835,400ABSTAIN: 3,380,061WITHHOLD: 5,917,847
Largest asset managers voting on “Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of Stockholde” at Edgewise Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard4,610,1600 00For
BlackRock00 2,864,4980Abstain
Fidelity1,561,3940 0542,894Mixed
JANUS INVESTMENT FUND00 01,438,908Withhold
Artisan856,3800 00For
American Century00 0613,417Withhold
Charles Schwab00 0579,704Withhold
MUTUAL FUND SERIES TRUST568,3100 08,025For
Aberdeen00 0443,319Withhold
Victory Capital00 0383,815Withhold
DRIEHAUS MUTUAL FUNDS00 0349,368Withhold
Federated Hermes00 0292,454Withhold
State Street00 0246,557Withhold
Equitable00 0193,862Withhold
TIAA193,4540 00For
Bridge Builder Trust00 162,3550Abstain
QUANTITATIVE MASTER SERIES LLC00 127,3880Abstain
AIG/SunAmerica00 0117,285Withhold
Lincoln Financial00 099,997Withhold
Jackson National00 88,1410Abstain
Prudential/PGIM00 074,554Withhold
ALPS ETF Trust00 068,275Withhold
TRUST FOR PROFESSIONAL MANAGERS00 64,0230Abstain
Neuberger Berman00 053,283Withhold
RBB FUND, INC.00 049,380Withhold

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

3. CONDUCT AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

97% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 196 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 64 asset managers voting on “CONDUCT AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at Edgewise Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard4,610,1600 00For
BlackRock2,864,4980 00For
Fidelity1,589,358514,930 00Mixed
JANUS INVESTMENT FUND1,438,9080 00For
Artisan856,3800 00For
American Century0613,417 00Against
Charles Schwab579,7040 00For
MUTUAL FUND SERIES TRUST576,3350 00For
Aberdeen443,3190 00For
Victory Capital383,8150 00For
DRIEHAUS MUTUAL FUNDS349,3680 00For
Federated Hermes292,4540 00For
State Street246,5570 00For
Equitable193,8620 00For
TIAA193,4540 00For
Bridge Builder Trust162,3550 00For
QUANTITATIVE MASTER SERIES LLC127,3880 00For
AIG/SunAmerica117,2850 00For
Lincoln Financial99,9970 00For
Jackson National88,1410 00For
Prudential/PGIM74,5540 00For
ALPS ETF Trust68,2750 00For
TRUST FOR PROFESSIONAL MANAGERS53,96410,059 00Mixed
Neuberger Berman53,2830 00For
RBB FUND, INC.49,3800 00For

Fund voting reports, all 64 managers: 15,944,610 for, 1,182,123 against, 6,575 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 152 asset managers voting on “CONDUCT AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at Edgewise Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
ORBIMED ADVISORS LLC15,245,7680 00For
RA CAPITAL MANAGEMENT, L.P.8,275,3450 00For
Novo Holdings A/S5,350,0000 00For
Janus Henderson5,313,7533,416 00For
Paradigm Biocapital Advisors LP5,194,7130 00For
PERCEPTIVE ADVISORS LLC4,589,2440 00For
BRAIDWELL LP3,587,2970 00For
Cormorant Asset Management, LP3,572,0670 00For
Siren, L.L.C.2,705,9150 00For
BlackRock2,502,28715,127 00For
DEERFIELD MANAGEMENT COMPANY, L.P.2,067,3200 00For
First Light Asset Management, LLC1,908,4880 00For
GEODE CAPITAL MANAGEMENT, LLC1,750,7720 00For
Deep Track Capital, LP1,700,0000 00For
DRIEHAUS CAPITAL MANAGEMENT LLC1,623,9720 00For
State Street1,570,41516,749 00For
MPM BioImpact LLC1,171,6390 00For
Artisan1,145,3110 00For
Woodline Partners LP1,140,0080 00For
Integral Health Asset Management, LLC862,1710 00For
American Century0648,190 00Against
Foresite Capital Management VI LLC585,0000 00For
Charles Schwab579,7090 00For
Sofinnova Investments, Inc.520,7570 00For
Fidelity0518,069 00Against

Institutional-manager reports, all 152 managers: 77,338,197 for, 1,565,926 against, 1,412 abstained, 65,345 not voted, 32,312 1 year. Showing the 25 largest; see all in the interactive database.

4. CONDUCT AN ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

99.9% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: votes by 192 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 64 asset managers voting on “CONDUCT AN ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE ” at Edgewise Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00--
BlackRock00 00--
Fidelity00 00--
JANUS INVESTMENT FUND00 00--
Artisan00 00--
American Century00 00--
Charles Schwab00 00--
MUTUAL FUND SERIES TRUST8,0250 00For
Aberdeen00 00--
Victory Capital00 00--
DRIEHAUS MUTUAL FUNDS00 00--
Federated Hermes00 00--
State Street00 00--
Equitable00 00--
TIAA00 00--
Bridge Builder Trust00 00--
QUANTITATIVE MASTER SERIES LLC00 00--
AIG/SunAmerica00 00--
Lincoln Financial45,5970 00For
Jackson National00 00--
Prudential/PGIM00 00--
ALPS ETF Trust00 00--
TRUST FOR PROFESSIONAL MANAGERS00 00--
Neuberger Berman00 00--
RBB FUND, INC.00 00--

Fund voting reports, all 64 managers: 53,622 for, 6,575 abstained, 17,058,409 1 year, 14,702 3 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 149 asset managers voting on “CONDUCT AN ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE ” at Edgewise Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
ORBIMED ADVISORS LLC00 00--
RA CAPITAL MANAGEMENT, L.P.00 00--
Novo Holdings A/S00 00--
Janus Henderson00 00--
Paradigm Biocapital Advisors LP00 00--
PERCEPTIVE ADVISORS LLC4,589,2440 00For
BRAIDWELL LP00 00--
Cormorant Asset Management, LP00 00--
Siren, L.L.C.00 00--
BlackRock00 00--
DEERFIELD MANAGEMENT COMPANY, L.P.00 00--
First Light Asset Management, LLC1,908,4880 00For
GEODE CAPITAL MANAGEMENT, LLC00 00--
Deep Track Capital, LP00 00--
DRIEHAUS CAPITAL MANAGEMENT LLC00 00--
State Street00 00--
MPM BioImpact LLC00 00--
Artisan00 00--
Woodline Partners LP00 00--
Integral Health Asset Management, LLC862,1710 00For
American Century00 00--
Foresite Capital Management VI LLC00 00--
Charles Schwab00 00Not Voted
Sofinnova Investments, Inc.00 00--
Fidelity00 00--

Institutional-manager reports, all 149 managers: 7,624,582 for, 453 against, 65,145 not voted, 71,131,040 1 year, 133,141 3 year. Showing the 25 largest; see all in the interactive database.

5. Advisory Vote on Say on Pay Frequency

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

— Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: votes by 4 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 1 asset manager voting on “Advisory Vote on Say on Pay Frequency” at Edgewise Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
FORUM FUNDS II00 00--

Fund voting reports, all 1 managers: 17,142 1 year.

Institutional-manager reports: 3 asset managers voting on “Advisory Vote on Say on Pay Frequency” at Edgewise Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Granahan Investment Management, LLC00 00--
JPMorgan00 00--
Desjardins Global Asset Management Inc.00 00--

Institutional-manager reports, all 3 managers: 266,648 1 year.

6. Advisory Vote to Ratify Named Executive Officers' Compensation

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

99.6% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 4 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 1 asset manager voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Edgewise Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
FORUM FUNDS II17,1420 00For

Fund voting reports, all 1 managers: 17,142 for.

Institutional-manager reports: 3 asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Edgewise Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Granahan Investment Management, LLC204,6430 00For
JPMorgan61,1310 00For
Desjardins Global Asset Management Inc.0874 00Against

Institutional-manager reports, all 3 managers: 265,774 for, 874 against.

7. RATIFY THE SELECTION OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING…

No official resultsAUDIT-RELATED

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 64 asset managers

Description as filed by funds: RATIFY THE SELECTION OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

The 64 asset managers below reported 17,126,733 for, 6,575 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 17,126,733ABSTAIN: 6,575
Largest asset managers voting on “RATIFY THE SELECTION OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDI” at Edgewise Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard4,610,1600 00For
BlackRock2,864,4980 00For
Fidelity2,104,2880 00For
JANUS INVESTMENT FUND1,438,9080 00For
Artisan856,3800 00For
American Century613,4170 00For
Charles Schwab579,7040 00For
MUTUAL FUND SERIES TRUST576,3350 00For
Aberdeen443,3190 00For
Victory Capital383,8150 00For
DRIEHAUS MUTUAL FUNDS349,3680 00For
Federated Hermes292,4540 00For
State Street246,5570 00For
Equitable193,8620 00For
TIAA193,4540 00For
Bridge Builder Trust162,3550 00For
QUANTITATIVE MASTER SERIES LLC127,3880 00For
AIG/SunAmerica117,2850 00For
Lincoln Financial99,9970 00For
Jackson National88,1410 00For
Prudential/PGIM74,5540 00For
ALPS ETF Trust68,2750 00For
TRUST FOR PROFESSIONAL MANAGERS64,0230 00For
Neuberger Berman53,2830 00For
RBB FUND, INC.49,3800 00For

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

Largest Edgewise Therapeutics, Inc. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 95,205,683 shares outstanding at the time of that meeting.

Fund voting reports: top Edgewise Therapeutics, Inc. shareholders by shares voted on “CONDUCT AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 4.84%
2BlackRock 3.01%
3Fidelity 2.21%
4JANUS INVESTMENT FUND 1.51%
5Artisan 0.90%
6American Century 0.64%
7Charles Schwab 0.61%
8MUTUAL FUND SERIES TRUST 0.61%
9Aberdeen 0.47%
10Victory Capital 0.40%
Institutional-manager reports: top Edgewise Therapeutics, Inc. shareholders by shares voted on “CONDUCT AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.”, 2024-2025
#Asset manager % of shares outstanding
1ORBIMED ADVISORS LLC 16.01%
2RA CAPITAL MANAGEMENT, L.P. 8.69%
3Novo Holdings A/S 5.62%
4Janus Henderson 5.58%
5Paradigm Biocapital Advisors LP 5.46%
6PERCEPTIVE ADVISORS LLC 4.82%
7BRAIDWELL LP 3.77%
8Cormorant Asset Management, LP 3.75%
9Siren, L.L.C. 2.84%
10BlackRock 2.64%

Reported Edgewise Therapeutics, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Edgewise Therapeutics, Inc. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
ORBIMED ADVISORS LLC 16.02% 13D
Baker Bros. Advisors LP 7.67% 13G
BlackRock 6.81% 13F
JANUS HENDERSON GROUP PLC 6.21% 13G
Novo Holdings A/S 5.62% 13D
Perceptive Advisors LLC 4.87% 13G
Vanguard Group 4.51% 13F
State Street 1.80% 13F
Millennium Management 0.72% 13F
Dimensional Fund Advisors 0.70% 13F

Percentages above are of 95,205,683 shares outstanding, as reported by Edgewise Therapeutics, Inc. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Edgewise Therapeutics, Inc.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 1, 2026; a live search always shows the current data.

At Edgewise Therapeutics, Inc.'s shareholder meeting held June 13, 2025, in the 2024-2025 proxy season, 199 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,392 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — CONDUCT AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — the reporting funds and managers cast 97% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Edgewise Therapeutics, Inc. proxy season coverage: 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.